When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CBIS - Lundbeck and Otsuka's combo treatment for PTSD successful in mid-stage study
Cannabis Science Inc
Otsuka Pharmaceutical Company (OTCPK:OTSKF)(OTCPK:OTSKY) and development partner H. Lundbeck A/S (OTC:HLUKF)(OTCPK:HLUYY) announce positive results from a Phase 2 clinical trial evaluating the combination of brexpiprazole and Pfizer's (PFE+0.7%) Zoloft (sertraline HCl) for the treatment of posttraumatic stress disorder (PTSD).
More news on: Otsuka Holdings Co. Ltd., Otsuka Holdings Co. Ltd. ADR, H. Lundbeck A/S, Healthcare stocks news,